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Campylobacteriosis is the most common cause of bacterial gastroenteritis worldwide.
Campylobacter species involved in this infection usually include the thermotolerant
species Campylobacter jejuni. The major reservoir for C. jejuni leading to human
infections is commercial broiler chickens. Poultry flocks are frequently colonized by
C. jejuni without any apparent symptoms. Risk assessment analyses have identified the
handling and consumption of poultry meat as one of the most important sources of
human campylobacteriosis, so elimination of Campylobacter in the poultry reservoir is
a crucial step in the control of this foodborne infection. To date, the use of probiotics
has demonstrated promising results to reduce Campylobacter colonization. This review
provides recent insights into methods used for probiotic screening to reduce the
prevalence and colonization of Campylobacter at the farm level. Different eukaryotic
epithelial cell lines are employed to screen probiotics with an anti-Campylobacter activity
and yield useful information about the inhibition mechanism involved. These in vitro
virulence models involve only human intestinal or cervical cell lines whereas the use
of avian cell lines could be a preliminary step to investigate mechanisms of C. jejuni
colonization in poultry in the presence of probiotics. In addition, in vivo trials to evaluate
the effect of probiotics on Campylobacter colonization are conducted, taking into
account the complexity introduced by the host, the feed, and the microbiota. However,
the heterogeneity of the protocols used and the short time duration of the experiments
lead to results that are difficult to compare and draw conclusions at the slaughter-age of
broilers. Nevertheless, the combined approach using complementary in vitro and in vivo
tools (cell cultures and animal experiments) leads to a better characterization of probiotic
strains and could be employed to assess reduced Campylobacter spp. colonization in
chickens if some parameters are optimized.
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INTRODUCTION
Food safety is of fundamental importance to the consumer, the food industry and the economy.
The incidence of foodborne diseases is still increasing in the European Union (EU) (Hugas et al.,
2009; EFSA, 2015), mainly caused by the presence and/or the growth of pathogenic bacteria in food.
Campylobacter and Salmonella are among the leading causes of bacterial foodborne illness and are
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therefore considered as major public health concern (Scallan
et al., 2011). In many countries, the number of human
campylobacteriosis cases has considerably increased to exceed
the number of Salmonella infections in humans by 2–3-fold
(EFSA, 2010). The disease is characterized by watery or bloody
diarrhea, abdominal cramps and nausea (Blaser et al., 2008).
Post-infection complications include peripheral neuropathies,
Guillain-Barré and Miller Fisher syndromes, and functional
bowel diseases, such as irritable bowel syndrome (Moore et al.,
2005). Hospitalization occurs in 10% of cases (Bessell et al.,
2010) and 0.2% end in death (Adak et al., 2005). In 2013, with
214,779 confirmed cases corresponding to a notification rate of
64.8 cases per 100,000 inhabitants, campylobacteriosis was the
most frequently reported zoonotic disease in humans in the
EU (EFSA, 2015). There are several species of Campylobacter
(C. jejuni, C. coli, C. lari, and C. upsaliensis) capable of causing
human illness. However, C. jejuni is the one most frequently
involved in zoonotic infections (Hugas et al., 2009). It is believed
to be responsible for 400–500 million cases of gastroenteritis
worldwide per year (Olson et al., 2008). Campylobacter cases are
often associated with very large costs, i.e., medical expenses, lost
wages, legal costs, and other indirect expenses. Only sporadic
data are available on the overall costs of Campylobacter infections
but campylobacteriosis and its sequelae in the EU are calculated
to cost 0.35 million disability-adjusted life-years per year, totaling
2.4 billion€ per year (EFSA, 2014). Annual costs for the US were
calculated to range between 1.2 and 4 billion $ (Batz et al., 2012;
Eberle and Kiess, 2012). Batz et al. (2014) estimated 16 QALY
(quality-adjusted life years) lost per 1000 campylobacteriosis
cases; with more than 828,500 cases annually reported, global
estimation is around 13,256QALY losses in theUS per year.More
recently, Scharff (2015) gives a QALY analysis for all foodborne
pathogens including Campylobacter.
Campylobacter is a commensal organism routinely found in
cattle, sheep, swine, and avian species, the latter being the most
common host. Numerous studies have already emphasized the
importance of poultry as a reservoir of Campylobacter (Herman
et al., 2003; Hermans et al., 2012; Sasaki et al., 2013) and
epidemiological evidence indicates poultry and poultry products
are a significant source of human infection (Mor-Mur and Yuste,
2010; EFSA, 2011). In particular, broiler meat is considered
the main foodborne source of Campylobacter human infection
(Nadeau et al., 2003; Nielsen et al., 2006; Silva et al., 2011;
EFSA, 2014). Recently, a national prospective case-control study
of factors associated with Campylobacter infection confirmed
that consumption of poultry remains an important exposure for
campylobacteriosis in Norway (MacDonald et al., 2015). Good
hygiene and biosecurity practices have been implemented to
avoid, or at least, reduce contamination (Gibbens et al., 2001)
but are considered as not sufficient (Hermans et al., 2011).
Considering this information, it is imperative to find a way to
minimize Campylobacter presence at the farm level in order to
reduce the risk of transmission throughout the processing stages.
Reducing the proportion of Campylobacter-infected poultry
flocks and/or reducing the number of Campylobacter in live
poultry will considerably lower the risk to consumers (Keener
et al., 2004; Westrell et al., 2009). Furthermore, prevention of
disease in humans and a reduction in the pathogen reservoir
in farm animals, without the need for antibiotics, are of both
ecological and financial benefit to society.
Regarding the emergence of antibiotic resistance in livestock
breeding (Schwarz and Chaslus-Dancla, 2001), poultry farmers
turned to new solutions to maintain animal welfare without
affecting performance parameters. Over the past years,
researchers are considering the use of probiotics as feed additives
in poultry nutrition (Kabir, 2009). Probiotics are usually defined
as “live microorganisms which, when administered in adequate
amounts, confer a health benefit on the host” (Hill et al., 2014).
In 2002, the United Nations FAO/WHO Working Group
generated new guidelines for the development and evaluation of
probiotics found in foods (Reid, 2005). They are acceptable and
cost-effective alternatives to antibiotics.
This review provides recent insights into the technological
and scientific advances to reduce the prevalence and colonization
of Campylobacter at the farm level with an emphasis on the
screening of probiotics.
CAMPYLOBACTER IN POULTRY
The prevalence of Campylobacter spp. in broiler chicken batches
varies considerably between EU countries; in 2008, it ranged
from 2 to 100% (average of 71%) (EFSA, 2010). In France,
Campylobacter is present at all stages of the food chain with a very
high prevalence of infection: 70–100% of broiler chicken batches
on their arrival at the slaughterhouse (Hue et al., 2010); 72–77%
of individual cecal portage during rearing and on arrival at the
slaughterhouse; 88% of carcasses and 76% of products at the
retail level (Chemaly et al., 2012; Guyard-Nicodème et al., 2015).
These results for France are broadly comparable to some high-
prevalence countries in the EU. Epidemiological studies have
identified potential risk factors associated with Campylobacter
colonization of flocks (Refrégier-Petton et al., 2001; Bull et al.,
2006; Allain et al., 2014; Robyn et al., 2015), including season
(Huneau-Salaün et al., 2007), drinking water quality (Ellis-
Iversen et al., 2009), or lack of hygienic barriers (Huneau-Salaün
et al., 2007).
Colonization of broiler flocks with Campylobacter species
typically occurs between 2 and 3 weeks of age (Newell et al.,
2011). The infection is mostly asymptomatic although chickens
can harbor very high levels of Campylobacter in the gut,
from 5 to 9 log10 CFU/g of cecal content (Saleha, 2002;
Hansson et al., 2010). Once in a flock, Campylobacter is rapidly
transmitted between birds by the fecal-oral route (Wassenaar,
2011) and Campylobacter-positive birds often remain colonized
until slaughter (Newell et al., 2011). During transport of birds
(Hansson et al., 2005) and carcass dressing, the surface of
broiler carcasses and the plant environment are contaminated
by fecal material from the gastrointestinal tract (Herman et al.,
2003; Rasschaert et al., 2006; Rosenquist et al., 2006; Reich
et al., 2008). Contamination of carcasses with Campylobacter
occurs mainly during defeathering, evisceration and chilling
operations (Sánchez et al., 2002; Stern and Robach, 2003;
Takahashi et al., 2006). The bacteria can thus survive during
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poultry processing through to human consumption, causing
subsequent illness as demonstrated by a Danish prospective
case-control study (MacDonald et al., 2015). Reducing the cecal
Campylobacter load in poultry during primary production is
expected to decrease significantly the contamination levels of the
carcasses of colonized animals after processing, and to reduce
the incidence of human campylobacteriosis (Lin, 2009; Hermans
et al., 2012).
CAMPYLOBACTER CONTROL AT FARM
LEVEL
A possible way to reduce Campylobacter contamination in
poultry is by actions at the primary production level. To
date, three general strategies have been proposed to control
Campylobacter in poultry at the farm level: (i) a reduction
in environmental exposure (Van de Giessen et al., 1998),
(ii) an increase in the poultry host’s resistance to reduce
Campylobacter carriage in the gut (Neal-McKinney et al., 2014),
and (iii) the use of antimicrobial alternatives to reduce and
even eliminate Campylobacter from colonized chickens (Ghareeb
et al., 2012).
Preventive strategy consists in the application of generic
control measures that have an impact on transmission routes
of pathogens; and therefore may reduce Campylobacter level in
poultry. This includes in particular biosecurity, good husbandry
as well as hygienemeasures. Biosecurity practices at the farm have
been reviewed by Newell et al. (2011) and include disinfecting
poultry houses, boot dips (Galanis, 2007), fly screens (Hald et al.,
2007), disinfecting equipment and vehicles, and treating the flock
water supply (Wassenaar, 2011). Nevertheless, contamination
is only reduced at the farm level while Campylobacter
remains widespread in the outside environment, for example
in other animal reservoirs (Devane et al., 2005). Once the
flock was infected by Campylobacter, biosecurity measures
became useless. Therefore, additional actions are necessary to
fight this foodborne pathogen (Hermans et al., 2011; Robyn
et al., 2015), such as vaccination, bacteriocin treatment, or
probiotics.
Strategies in Progress
Complementary practices currently being investigated (Table 1)
include vaccination (De Zoete et al., 2007; Meunier et al.,
2016b), bacteriocins (Svetoch and Stern, 2010; Messaoudi et al.,
2012a), bacteriophages (Monk et al., 2010), prebiotics (Gaggìa
et al., 2010), and probiotics (Kergourlay et al., 2012; Messaoudi
et al., 2012b, 2013). To date, there are still no effective and
consistent immune interventions, primarily due to the lack
of understanding of the protective immunity, the antigenic
variability of different Campylobacter strains, and the inability
of current vaccination to induce a strong and persistent
mucosal immune response in chickens (Meunier et al., 2016a).
Studies using bacteriophages showed that they were partly and
temporally effective in reducing Campylobacter in broilers. This
could be explained by the fact that Campylobacter develop
resistance to bacteriophages (Janež and Loc-Carrillo, 2013) and
that these may be strain-specific and only effective against certain
Campylobacter strains (Loc-Carrillo et al., 2005).
Interestingly, prebiotics and bacteriocins can be used together
to probiotics to potentially increase the anti-Campylobacter
activity. Prebiotics are non-digestible ingredients, such as
fructo-oligosaccharides (Patterson and Burkholder, 2003), which
enhance the growth of gut commensal bacteria that have
probiotic properties, i.e., Bifidobacterium (Bf.) and Lactobacillus
(Lb.) (Roberfroid, 1998), while bacteriocins are ribosomally-
synthesized antimicrobial peptides produced by bacteria. Few
studies have been conducted to evaluate the efficacy of prebiotics
in reducing Campylobacter colonization in poultry. The addition
of mannanoligosaccharide to the feed of naturally-infected
birds and xylanase to artificially-infected broilers resulted in a
statistically significant decrease of 0.3 log in cecal C. jejuni counts
(Baurhoo et al., 2009). Concerning bacteriocins, for example,
Messaoudi et al. (2012a) showed that the viable population of
C. jejuni NCTC 11168 pure cultures decreased by 2 log when
growth was performed in the presence of salivaricin SMXD51.
Administration of enterocin E-760-treated feed significantly
reduced the colonization of young broiler chicks experimentally
challenged and colonized with two strains of C. jejuni by more
than 8 log CFU (Line et al., 2008). Another in vivo study
TABLE 1 | Strategies in progress to control Campylobacter at the farm level.
Strategy Principle Advantage Drawback
Vaccination Improvement of the immune response against
Campylobacter
Easy to use Antigenic variability of Campylobacter strains
Bacteriophage
therapy
Use of specific bacterial virus to kill Campylobacter Rapid action Selection of resistant Campylobacter strains
Production cost
Diversity of Campylobacter strains
Bacteriocin
treatment
Use of bacteria-produced antimicrobial compounds
against Campylobacter
Easy to use Production cost
Variable sensitivity of Campylobacter strains
Prebiotics Incorporation of feed additives to improve beneficial
avian gut microbiota
Easy to use
Production cost
Dependence on the avian gut microbiota
Probiotics Administration of beneficial microorganisms with
anti-Campylobacter activity
Easy to produce and to use
Production cost
Mix of multiple species
Different ways of inhibiting Campylobacter
Variable sensitivity of Campylobacter strains
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on chickens infected with C. jejuni and Salmonella enteritidis,
demonstrated that treatment with L-1077, the bacteriocin
produced by Lb. salivarius NRRL B-50053, reduced by more
than 4 log the number of bacteria per gram of cecal content
(Svetoch et al., 2011). Majority of the bacterial antimicrobial
peptides active against C. jejuni were isolated from Bacillus and
Paenibacillus spp., and from the lactic acid bacteria (Lohans
et al., 2015). Svetoch and Stern (2010) have reviewed bacteriocin
applications to reduce the cecal Campylobacter counts in broiler
chickens of colonized flocks. This strategy is of limited relevance
for the moment because purity and yields of bacteriocins, after
purification, are low. This could be due, in part, to their low
molecular weight and to the design of the purification processes
employed so far (Carolissen-Mackay et al., 1997). In addition,
hydrophobic peptides are often only produced in small amounts
(Berjeaud and Cenatiempo, 2004). But efforts are underway and
current strategies to enhance yield of bacteriocins were recently
described by Zacharof (2015).
Prohibition of antibiotics in poultry feed in Europe and the
problems inherent in developing new vaccines make probiotics a
promising prophylactic alternative to control C. jejuni in broiler
chickens during rearing at the farm level (Table 1). They could act
in multiple ways, at the same time, against pathogens in contrast
to other more specific strategies (vaccination or bacteriophages)
(Figure 1). In fact, probiotics are already used in the poultry
industry for preventing or reducing the occurrence of Salmonella
infection in poultry and for enhancing the growth performance
of broiler chickens (Tellez et al., 2013). Their impact on poultry
nutrition is of great importance for the proper utilization of
nutrients.
Probiotics: Attractive and Natural
Antimicrobial Agents
Being living microorganisms, probiotics can stimulate gut
microbiota which contributes to keep the host healthy (Fuller,
1989; Sanders, 2011). Based on in vitro assays, thesemodifications
include stimulation of the immune system (Smits et al., 2005),
acidification of the environment (Ogawa et al., 2001), secretion
of active metabolites against pathogens, such as bacteriocins
(Marcinˇáková et al., 2004) or hydrogen peroxide (Batdorj et al.,
2007), and competition with the pathogens for nutrients or sites
for adherence on the mucous membrane or the host epithelial
FIGURE 1 | Potential pathways of the strategies in progress to reduce
avian gut pathogens in poultry. Red arrows represent probiotic pathways.
cells (Bernet et al., 1994). These abilities can be useful to control
pathogen infection and probiotic treatment has been linked
with beneficial effects against gastrointestinal pathogens using
animal models. For example, a mixture of Lactobacillus spp.
strains reduced gastric inflammation and bacterial colonization
in Helicobacter pylori-infected mice (Johnson-Henry et al.,
2004). A five-strain probiotic combination (two strains of
Lb. murinus and one strain each of Lb. salivarius, Lb. pentosus,
and Pediococcus pentosaceous) reduced pathogen shedding and
alleviated disease signs in pigs challenged with S. enterica
serovar Typhimurium (Casey et al., 2007). Pascual et al. (1999)
showed that a treatment with Lb. salivarius CTC2197 prevented
S. enterica serovar Enteritidis colonization in chickens. In
addition, some probiotic strains as feed supplements can also
prevent gastrointestinal infection in broiler chickens (Tellez et al.,
2001).
As probiotics inhibit foodborne pathogens such as Salmonella
(Nurmi and Rantala, 1973), often designated as competitive
exclusion, they could potentially have an effect on Campylobacter
(Figure 2). Indeed, probiotic bacteria successfully excluded
C. jejuni frommice (Sorokulova et al., 1997; Wagner et al., 2009).
Regarding chickens, potential probiotic mechanisms associated
with the inhibition of Campylobacter have been reviewed and
detailed by Mohan (2015).
The general strategy for the selection of probiotic strains
requires a set of experiments to identify the most promising
candidates (Figure 3). In vitro studies include aggregation, co-
aggregation, cell surface hydrophobicity and adhesion activities
on epithelial cells. Additionally, growth with bile acids (chicken
bile) and tolerance to acidic pH are checked. In addition to
in vitro assays, in vivo experiments on chickens are carried out
to highlight the impact of probiotics on foodborne pathogen
colonization and/or the effect on growth performances in
animals. This strategy includes simplified in vitro assays for
probiotic screening, followed by more complex in vivo trials to
confirm the anti-Campylobacter activity (Figure 4).
IN VITRO SCREENING FOR
ANTI-CAMPYLOBACTER PROBIOTICS
In vitro studies are preliminary screening tools for the
selection of potential probiotic cultures, and the first stage
for further application in poultry production. Based on tests
that confirm some antimicrobial properties, several potential
anti-Campylobacter bacteria have been isolated (Table 2). A
whole set of experiments can be carried out to identify the
mechanism involved in the anti-Campylobacter activity. The
ability to inhibit the pathogen’s growth can be evaluated by co-
culture experiments as well as by antimicrobial assays with cell-
free culture supernatant, while interference with the adhesion
to/invasion of intestinal cells can be studied by adhesion and
invasion inhibition assays.
Probiotic Identification
Identification of probiotic strain at species level is still
important as the GRAS (Generally Recognized As Safe)
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FIGURE 2 | Potential probiotic abilities to reduce Campylobacter in the avian gut. (1) Probiotics produce acidic compounds (lactic acid), which could inhibit
Campylobacter and reduce the gut luminal pH that could affect Campylobacter (Neal-McKinney et al., 2012). (2) Probiotics compete for nutrients with Campylobacter
(Aho et al., 1992). (3) Probiotics produce bactericidal substances (bacteriocins, H2O2) that could kill Campylobacter (Messaoudi et al., 2012a). (4) Probiotics
strengthen tight junctions of intestinal epithelium and prevent Campylobacter translocation (Messaoudi et al., 2012b). (5) Probiotics colonize intestinal epithelium and
prevent adhesion and invasion of Campylobacter (Wine et al., 2009). (6) Probiotics bind Campylobacter (Nishiyama et al., 2014). (7) Probiotics alter the avian gut
microbiota, which could affect Campylobacter colonization (Sanders, 2011). (8) Probiotics modulate the immune system, which acts against Campylobacter (Brisbin
et al., 2011).
FIGURE 3 | Overall strategy to select potential probiotics to control Campylobacter in chickens.
and QPS (Qualified Presumption of Safety) status defined
in USA and Europe, respectively, are both based on the
species name. Traditional methods for bacterial identification
and phenotypical characterization, such as API system,
BIOLOG or culture-based techniques can be used to identify
probiotics strains (Herbel et al., 2013; Bagheripoor-Fallah
et al., 2015; Galanis et al., 2015; Cherdyntseva et al., 2016).
For instance, the main phenotypic methods for Lactobacillus
probiotic identification were discussed in Herbel et al. (2013).
However, these conventional microbiological tests may have
limitations in discriminating large numbers of isolates with
similar physiological characteristics (Herbel et al., 2013;
Frontiers in Microbiology | www.frontiersin.org 5 May 2016 | Volume 7 | Article 553
Saint-Cyr et al. Screening of Probiotics to Control Campylobacter in Chickens
FIGURE 4 | Progressive complexity of methods used to select probiotics with in vitro and in vivo anti-Campylobacter activity. Simplified in vitro assays to
assess direct interactions between the probiotic and Campylobacter (1) without (co-culture and agar plate diffusion) or (2) with an intestinal environment (co-culture in
batch) or (3) interactions between the probiotic, Campylobacter and intestinal epithelial cells (adhesion and invasion assays). Complex in vivo trials (4) with their
potential interactions to corroborate in vitro assays. Black arrows represent potential interactions. Green represents the intestinal environment.
Bagheripoor-Fallah et al., 2015; Yadav and Shukla, 2015). In
addition, culture-based techniques provide strains able to
replicate under experimental conditions, indeed selective media
exist only for a limited subset of potential strains of interest
(Davis, 2014).
Several DNA-based techniques have been developed to
overcome this obstacle (Bagheripoor-Fallah et al., 2015; Yadav
and Shukla, 2015), such as the pulsed field gel electrophoresis
(PFGE) mainly used for probiotic strain differentiation
and discrimination (Tynkkynen et al., 1999; Gosiewski and
Brzychczy-Wloch, 2015). However, it cannot be applied for direct
detection of a particular strain, in a single reaction (Tynkkynen
et al., 1999). Moreover, it is laborious, time-consuming and,
thus, inappropriate for large scale screening experiments from
environmental samples, especially when microbial groups, other
than those needed to be identified, are at higher population
levels. In addition, the PCRmethodology (mostly on 16S and 23S
ribosomal RNA) coupled to sequencing is commonly employed
for efficient identification of lactic acid bacteria (Allegretti et al.,
2014; Yadav and Shukla, 2015; Cherdyntseva et al., 2016). It
is easy to implement, fast, cost efficient, and requires a small
amount of template DNA. However, when the design of specific
primers is not feasible, the random amplified polymorphic
DNA (RAPD) technique may be applied. RAPD is a PCR-based
assay that uses short arbitrary primers that anneal to multiple
random target sequences to generate the needed polymorphism
(Galanis et al., 2015). A recent article published by Yadav and
Shukla (2015) reviewed molecular and analytical techniques to
identify and screen probiotics. Among the methods discussed,
quantitative analysis by real-time PCR (RT-PCR or qPCR) and
fluorescent based-methods (fluorescent in situ hybridization and
fluorescent activated cell sorting) enables the discrimination
of different species and to quantify the amount of bacteria
used in a sample (Herbel et al., 2013; Yadav and Shukla, 2015).
These last years, development of new techniques to improve
bacterial strain identification and characterization is facilitated
by the next-generation sequencing (NGS) technologies (Herbel
et al., 2013). These techniques would allow identification of
non-cultivable strains and also analyze of metabolites produced
by probiotics by metabolomics. In addition, whole genome
sequencing (WGS) offers an insight regarding evolutionary
background and diversity of lactic acid bacteria belonging to
one species (Herbel et al., 2013). For example, comparative
genome analysis of published Lb. salivarius sequences led to
the identification several genes known to be important for
gastrointestinal survival, adherence to cells, and bacteriocin
production in Lb. salivarius SMXD51 (Kergourlay et al., 2012).
Growth Inhibition Assays
This first step of screening consists of monitoring Campylobacter
growth in the presence of the probiotic in a co-culture assay or
its supernatant in an agar plate diffusion assay (Table 2). This
method is easy, applicable to a large number of test strains and,
in addition, does not require expensive laboratory equipment.
Using this approach, Lb. acidophilus and Lb. gasseri have been
shown to inhibit strongly C. jejuni by lactic acid production
(Fernández et al., 2003). Similarly, the ability of Lactobacillus
spp. isolated from chickens to inhibit the growth of C. jejuni
has been demonstrated by Chaveerach et al. (2004). These results
suggest that the inhibitory effect of Lactobacillus strains on
Campylobacter growth is a combination of organic acid and
bacteriocin production (Chaveerach et al., 2004). These findings
have been supported by Dubois Dauphin et al. (2011) who
observed the antimicrobial effect of E. faecium THT due to lactic
acid production and Lb. pentosus CWBI B78 due to lactic and
acetic acid production. Messaoudi et al. (2011) identified three
Lb. salivarius strains, i.e., SMXD51, MMS122, and MMS151,
from chicken ceca with antagonism against C. jejuni strains
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NCTC 11168 and 81–176 due to the production of bacteriocins.
Recently, Lb. fermentum ATCC 1493, Lb. johnsonii BFE 663 and
Lb. paracasei IMT 22353 showed antimicrobial activity against
C. jejuni NCTC 11168 and C. jejuni CIP 70.2 (Bratz et al.,
2015). It turned out that the anti-Campylobacter activity of the
Lactobacillus strains was pH-dependent, i.e., pH< 4.3.
In vitro fermentation experiments under controlled
temperature, pH and atmosphere were carried out to elucidate
further the ability of probiotics to inhibit Campylobacter growth
under conditions simulating those in broiler ceca. Chang and
Chen (2000) demonstrated an antagonistic effect on C. jejuni
by four lactobacilli, including Lb. acidophilus, Lb. fermentum,
Lb. crispatus, and Lb. brevis, in a complete simulated digestive
tract model. Similarly, Robyn et al. (2012) showed the in vitro
anti-Campylobacter activity of E. faecalis MB 5259. Even though
the model mimics the broiler cecal environment, i.e., pH and
bile salts, and anaerobic incubation, a major limitation of this
approach is the lack of epithelial cells and avian gut microbiota
that compose the intestine.
Adhesion and Invasion Inhibition Assays
The inhibition assays described in Section Growth Inhibition
Assays are not solely suitable to confirm the anti-Campylobacter
effect of probiotics because these experiments do not take into
account the complexity of interactions occurred in vivo, whose
interaction with the epithelial intestinal cells. Thus, a better
characterization of the mechanisms of action of probiotic strains
on Campylobacter is required. Another screening step is to
test the ability of the probiotic strain to inhibit or modulate
Campylobacter infection in epithelial intestinal cells. Probiotic
and pathogen are incubated with intestinal monolayer cells and
then all the pathogens that adhere to and invade eukaryotic cells
are enumerated in order to determine the adhesion and invasion
indexes. In addition, the number of probiotic cells that adhered
to the monolayer could be also counted to assess the adhesion
ability of the probiotic strain. The possible impact of the probiotic
on the structure and integrity of the eukaryotic cells could be also
evaluated to provide useful information on the mode of action of
the probiotic.
Although the purpose of the in vitro experiments presented
in the Table 1 is to highlight the anti-Campylobacter activity of
probiotics for further application at the farm level, particularly in
poultry farms, no in vitro experiments including avian intestinal
cell lines have been carried out as, to our knowledge, these cell
lines are not yet commercialized. For example, Van Deun et al.
(2008) used ceca from commercial brown laying hens at the age
of 12–20 weeks to isolate primary epithelial cells from crypts
according to a modified protocol of Booth et al. (1994), which
requires specialized expertise (Booth et al., 1994; Van Deun et al.,
2008). It is worth noting that the LMH cell line (Kawaguchi et al.,
1987) is the only chicken epithelial cell line currently available
to researchers from the ATCC culture collection (Larson et al.,
2008). LMH is a primary hepatocellular carcinoma epithelial
cell line and has been used previously as an in vitro model
to investigate mechanisms of C. jejuni colonization in poultry
(Smith et al., 2005; Byrne et al., 2007). Although the LMH
chicken epithelial cells are derived from the liver, the results
obtained with this cell line in vitro were correlated with in vivo
findings (Konkel et al., 2007). In addition, Smith et al. (2005) and
Byrne et al. (2007) reported that C. jejuni isolates invade chicken
primary cells and human cells at comparable levels. In contrast
to these results, Larson et al. (2008) found that C. jejuni invades
chicken LMH epithelial cells in significantly lower numbers (0.6–
1.7 log differences) than it invades human INT 407 epithelial
cells, although the bacterial adhesion assays showed that C. jejuni
adhere to LMH cells and INT 407 cells in comparable numbers.
The chicken LMH cell line has also been used to evaluate the
adhesion of Lactobacillus cultures to epithelial cells (Spivey et al.,
2014). Thus, LMH epithelial cells may represent an alternative
cell line for the investigation of probiotic functionality and
mechanistic studies, but efforts should be made to develop a
stable avian intestinal cell line.
On the contrary, the in vitro human cell lines are well
established and have been used for many years to investigate
specific aspects of small intestinal function. They could reflect
the interaction between the pathogen and the probiotic bacteria.
They are useful for the evaluation of the immunomodulation
activity of probiotic strains, by assaying cytokine production
(Ashraf and Shah, 2014; Vitaliti et al., 2014; Frei et al., 2015).
Moreover, as shown previously, several steps of C. jejuni
pathogeny, including adhesion, invasion and translocation, could
be assessed using these cell lines (Haddad et al., 2010a,b).
Thereby, this model may help to clarify whether probiotic
strains prevent or reduce damage to epithelial integrity caused
by a pathogenic challenge. Although this model does not
completely reflect the in vivo setting, it does provide a
valuable opportunity to study the interactions between the
enteric pathogen, potentially beneficial microorganisms, and host
epithelial cells.
The different experiments involving epithelial cells are
described and summarized in Table 2. Most studies showed
slight reductions in adhesion and invasion ranging from 8
to 70%. For example, a 55% reduction in the invasion of
human intestinal epithelial cells by C. jejuni was observed
after treatment with Lb. helveticus R0052, which suggested
that competitive exclusion could contribute to protection by
adherent probiotics (Wine et al., 2009). One important point
highlighted by these authors is the strain specificity of the
described effects. Their results demonstrated that Lb. helveticus
R0052 is more effective than either Lb. rhamnosus R0011
or Lb. rhamnosus GG in interfering with C. jejuni invasion
of intestinal epithelial cells. This observation highlights the
complexity of the interactions between microorganisms and
mammalian cells.
Similarly, probiotics attenuated C. jejuni association with and
internalization within HT29-MTXE12 cells, and translocation of
the bacteria to the basolateral medium of transwells (Alemka
et al., 2010). The studies mentioned above emphasized probiotics
as a preventive/protective measure to limit Campylobacter
infection. Interestingly, HT29-MTXE12 cells are a cell line that
provides an opportunity to study the role of mucus in vitro,
and the relationship of mucus-associated factors with the anti-
Campylobacter activity of probiotics, as Campylobacter inhabits
the mucus layer in the avian host (Van Deun et al., 2008).
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Simplified models with mucin (Tareb et al., 2013) or chicken
intestinal mucus (Ganan et al., 2013) showed that probiotics
were able to reduce the binding of Campylobacter spp. when the
probiotics colonized the mucus before the pathogen (Table 2).
Campana et al. (2012) also observed the inhibitory properties
of Lb. acidophilus ATCC 4356 on Caco-2 cell adhesion
to/invasion ofC. jejuni. More recently,Wang et al. (2014) isolated
four adhesive Lactobacillus strains able to exert significant
antagonistic activity against C. jejuni in vitro and to promote
effective inhibition of the adhesion to and invasion of HT29 cells
by C. jejuni. Their bactericidal capacity is probably related to the
low pH and the production of metabolites, such as lactic acid and
antibiotic-like substances. These last two works emphasized the
beneficial effects of probiotics not only as a preventive/protective
measure but also as a therapeutic one.
Several limitations of these kinds of experiment need to
be reported. C. jejuni isolates from humans, chickens or pigs
are capable of adhering to and invading human, avian and
porcine cell lines (Biswas et al., 2000; Gripp et al., 2011) with
different efficiencies (Poly et al., 2007; Larson et al., 2008;
Wine et al., 2008). Moreover, the capabilities between strains
vary significantly (Newell et al., 1985; Fauchere et al., 1986;
Biswas et al., 2000; Fearnley et al., 2008; Zheng et al., 2008).
It is also well-known that Campylobacter spp. exhibit high
genetic and phenotypic variability and flexibility (Gripp et al.,
2011; Rodrigues et al., 2015; Bronnec et al., 2016), and, as a
consequence, are not equally virulent and probably not equally
sensitive to probiotic actions (Wine et al., 2009).
Another limitation is the growth conditions, which are very
beneficial for the bacteria but do not reflect a realistic intestinal
environment. Similarly, in almost all the studies described in
Table 2, experiments and strain cultures were carried out at 37◦C,
which is not in accordance with the temperature of chicken, i.e.,
42◦C. This difference could have an impact on the in vitro anti-
Campylobacter activity. For example, it has been documented
that bacteriocin production can be sensitive to environmental
changes and parameters including temperature, pH and growth
medium (Cintas et al., 2000; Diep et al., 2000; Qi et al., 2001).
Therefore, the models used are not optimized to characterize
completely C. jejuni virulence or colonization, and thus the effect
of probiotics on the infection biology of this pathogen.
Despite these limitations, the techniques mentioned (Table 2)
are relevant for initially screening probiotic strains with anti-
Campylobacter activity and speculating on the mechanisms
involved. However, improved adhesion and invasion inhibition
assays would use an avian intestinal cell line that secretes
mucus, an incubation temperature of 42◦C (temperature of
chicken), field Campylobacter strains (isolated from chicken),
and a reference strain. This strain of choice should exhibit
efficient adherence and invasion characteristics but also robustly
infect animal models (Ahmed et al., 2002; Seal et al., 2007; Hiett
et al., 2008). These strains, such as NCTC 11168, 81–176, RM1221
and 81116, are the most commonly used isolates in laboratories
and have been successfully used for in vitro and in vivo infection
studies. Such reference strains will ensure a critical comparison of
the impact of probiotics between the different studies performed.
In addition, complete genome sequences of these reference
strains are available and could allow further investigations of the
interactions between pathogens and probiotics at the genomic
level (Parkhill et al., 2000; Fouts et al., 2005; Gundogdu et al.,
2007; Pearson et al., 2007).
Nevertheless, the results obtained need to be confirmed by
in vivo experiments because in vitro experiments do not take
into account major parameters (Figure 4), such as avian gut
microbiota, immune response and feed, which could interact
with the probiotic and its anti-Campylobacter activity.
ANTI-CAMPYLOBACTER ACTIVITY OF
PROBIOTICS IN BROILERS
Many early reports showed that the administration of probiotics,
especially Lactobacillus and Bifidobacterium, improved growth
performances in animals such as broilers by increasing the
utilization of nutrients (Jin et al., 1998). An overview of the effects
of probiotics was given by Oelschlaeger (2010). Among them,
the exclusion of pathogens (Tsai et al., 2005) seems to be a valid
approach to counteract foodborne pathogen contamination.
Published in vivo studies, summarized in Table 3, have pointed
out a possible role of probiotics in preventing the shedding of
C. jejuni at the level of primary production.
Probiotics Used Alone
Several studies suggest that a therapeutic treatment could be
useful in suppressing C. jejuni colonization of chicks at early
growth stages (Table 3). Birds fed diets including Bacillus subtilis
C-3102 had significantly reduced numbers of Campylobacter (0.2
log) than birds fed with the control diet (Fritts et al., 2000). Neal-
McKinney et al. (2012) found that the number of C. jejuni was
reduced by almost two orders ofmagnitude in commercial broiler
chickens fed with Lb. crispatus showing a potential role of the
probiotic as a preventive/protective measure. After investigating
possible mechanisms for this reduction, including production
of bacteriocins, stimulation of antibody production, alteration
of the cecal microbiome, and production of lactic acid, the
authors concluded that only the production of lactic acid was
supported by their data (Neal-McKinney et al., 2012). Recently,
Nishiyama et al. (2014) demonstrated the ability of Lb. gasseri
SBT2055 to inhibit the adhesion and invasion of C. jejuni in
vitro and C. jejuni colonization of chicks in vivo. Their data
suggested a pivotal role for APF1 in mediating the interaction of
LG2055 with human intestinal cells and in inhibiting C. jejuni
colonization of the gastrointestinal tract (Nishiyama et al., 2015).
Recently, Arsi et al. (2015a) collected bacterial isolates (Bacillus
spp.) with anti-Campylobacter activity in vitro and evaluated
their efficacy in vivo after oral or intracloacal inoculation into
chicks. They demonstrated that, when dosed orally, only one
isolate had a 1 log reduction in cecal Campylobacter counts,
whereas when administered intracloacally, six isolates produced
a 1–3 log reduction in cecal Campylobacter counts in 14-day-
old chickens (Arsi et al., 2015a). Their results highlight the
fact that if probiotics are protected during transit through the
upper gastrointestinal tract and are thus available in the lower
intestinal tract, they could reduce Campylobacter colonization
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in broiler chickens. This is also the first study to show an
anti-Campylobacter effect of a single probiotic on a four-strain
mixture of Campylobacter.
Contrary to these results, treatments with viable probiotic
bacterial cultures (Lb. salivarius NRRL B-30514 or Paenibacillus
polymyxa NRRL B-30509) were ineffective in reducing
C. jejuni in chickens, using both prophylactic or therapeutic
administration (Line et al., 2008), while treatment with
bacteriocins from these corresponding bacteria substantially
reduced C. jejuni colonization in live chickens (Svetoch et al.,
2005). Finally, this anti-Campylobacter activity of P. polymyxa
was not due to a bacteriocin and was reassigned to the
lipopeptide tridecaptin A1 (Lohans et al., 2014). Another study
showed that in vitro activity of Bf. longum PCB 133 against
C. jejuni was confirmed in in vivo trials while Lb. plantarum PCS
20 failed to show any efficacy (Santini et al., 2010). Netherwood
et al. (1999) also showed no evidence of a beneficial effect on
the shedding of Campylobacter by chickens treated with the
probiotic E. faeciumNCIMB 11508. This result was corroborated
by Robyn et al. (2013) with another Enterococcus strain. No
evidence for inhibition was identified after challenging the
probiotic E. faecalis MB 5259 with Campylobacter in broilers,
although an in vitro inhibitory influence of the E. faecalis strain
on C. jejuni had previously been shown in a system mimicking
the broiler cecal environment (Robyn et al., 2013).
As a general remark, studies using probiotics individually
have demonstrated heterogeneous results (Table 3). The presence
of the complex avian gut microbiota, which could interact
with the anti-Campylobacter activity, might partly explain this
difference between in vitro and in vivo results. Thus, an
effective alternative can be combinations of probiotic strains,
which individually show anti-Campylobacter activities such as
aggregation, competition for site adhesion, bacteriocin and acid
production.
Probiotic Mixture
In their search for a competitive flora against Campylobacter,
Aho et al. (1992) isolated two K-bacteria, i.e., two strains
of Campylobacter-like organisms, from the ceca of an adult
hen. They found that these mucin-adapted microaerophilic
bacteria combined with Broilact R© (Nimrod Veterinary Products,
Gloucester, United Kingdom) a commercial mix of facultative
anaerobic bacteria, delayed the onset of Campylobacter
colonization by 1.5 weeks, and maintained a low level of
colonization of 1.5–2 log10 CFU/g in broiler chickens (Aho et al.,
1992). These bacteria, as a preventive/protective measure, may
compete with Campylobacter for the same ecological niche in
the intestinal ecosystem. Nevertheless, the problem with using
undefined bacterial mixtures was that the antagonistic activities
of the supplied bacteria were not well understood and presented
the potential risk of introducing avian or human pathogens
into the food chain (Stavric, 1992). This study appears to be in
line with Schoeni and Wong (1994) who found that a defined
mixture of Citrobacter diversus, Klebsiella pneumoniae, and
Escherichia coli reduced the colonization of Campylobacter by
62% in chicken. Morishita et al. (1997) orally administered a
mixture of Lb. acidophilus and Streptococcus faecium (isolated
from chicken gut) to chickens in their drinking water for the
first 3 days of life. Six hours after the first treatment, they orally
challenged them with C. jejuni. Chickens receiving the treatment
were significantly less colonized with C. jejuni (70% reduction)
than those in the control group. Similarly, Willis and Reid (2008)
showed a lower level of C. jejuni in broiler chickens fed with a
standard diet supplemented with a probiotic mixture containing
Lb. acidophilus, Lb. casei, Bf. thermophilus, and E. faecium (108
CFU/g).
Ghareeb et al. (2012) infected 1-day-old broiler chicks, which
then received 2 or 20mg/chick per day of a commercialized
probiotic via their drinking water for 15 days. The protective
administration of the multispecies probiotic product, containing
avian-derived Enterococcus, Pediococcus, Lactobacillus, and
Bifidobacteriummicroorganisms, to broiler chickens reduced the
cecal colonization by 3.8–5.5 log of C. jejuni at both 8 and 15
days post-challenge and may have changed their gut microbiota
in a way that is beneficial to the health of consumers by reducing
the number of Campylobacter (Ghareeb et al., 2012). Cean et al.
(2015) went a step further and investigated the presence of
the pathogen in the feces, duodenal and cecal content and the
duodenal and cecal mucosa after a 42-day treatment with a
combination of Lb. paracasei J.R., Lb. rhamnosus 15b, Lb. lactis
Y, and Lb. lactis FOa. A significant reduction in the pathogen
load from 0.5 to 5 log in both intestinal content and mucus
colonization was observed (Cean et al., 2015). The highest effect
of the mixture was observed in the duodenal content while
the reduction in Campylobacter loads in the cecal content was
the lowest. This observation highlights that probiotic activity
may depend on the part of gastrointestinal tract considered and
suggests that probiotic concentrations may be lower in the ceca
than in the duodenum and/or Campylobacter may be better
protected in the ceca. In addition, these probiotics were effective
even when introduced in broiler feed 7 days before slaughter, thus
as a therapeutic measure.
Recently, Baffoni et al. (2012) evaluated the therapeutic ability
of a synbiotic mixture of Bf. longum PCB133 and prebiotic
oligosaccharides to reduce the presence of C. jejuni in broiler
chicken gut. In their in vivo experiment, C. jejuni quantification
showed a 0.5 log decrease while total bifidobacteria were
significantly increased after 2 weeks of treatment compared
with the control group. On one hand, they speculated
that the increased number of bifidobacteria, determined by
prebiotic oligosaccharide intake, helps modulate the expression
of Campylobacter genes involved in adhesion, as reported
by Ding et al. (2005). On the other hand, the probiotic
strain PCB133 exerts an anti-Campylobacter effect through
antibacterial metabolite production, mainly acidic products, as
well evidenced in the literature for other probiotic strains
(Marianelli et al., 2010). These results illustrate the concept of
synbiotics, which is a synergistic combination of probiotics and
prebiotics (Roberfroid, 1998).
By targetingmotility properties of bacteria in the development
of probiotic cultures, Aguiar et al. (2013) selected three B. subtilis
sp. with enhanced motility. The mixture, administered on the
day of hatching, was able to reduce C. jejuni colonization in
chicken challenged with a mixture of four different wild-type
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strains of C. jejuni. These motility-selected bacteria may have
the marked ability to reach the same gastrointestinal niche in
poultry, i.e., cross the protective avian intestinal mucus and
reach cecal crypts, and then competitively reduce C. jejuni. Their
findings support the theory that the motility enhancement of
potential probiotic bacteria may provide a strategy for reduction
ofC. jejuni in chickens. This is also the first study to show an anti-
Campylobacter effect of a probiotic mixture administrated once
(day of hatching) on a four-strain mixture of Campylobacter.
Critical Parameters of In vivo Trials
Figure 5 presents a comparison of commercial broiler chicken
production and in vivo studies with an emphasis on the duration
and timing of Campylobacter contamination.
Most commercial broilers reach slaughter-weight between
5 and 7 weeks of age, although slower growing races reach
slaughter-weight at approximately 14 weeks of age. As indicated
in Table 3 and illustrated in Figure 5, almost all in vivo studies
have only lasted from 2 to 4 weeks. Thus, it may be very difficult
to conclude about the positive or negative effectiveness of the
tested probiotics at the slaughter-age of broilers. On one hand,
studies may not take into account the resilience of Campylobacter
to the presence of probiotic in the intestinal environment.
The pathogen might implement strategies to overcome the
anti-Campylobacter activity, as they do against bacteriophages
(Hammerl et al., 2014) and then, despite a decrease at the
beginning, the pathogen could adapt and grow oncemore. On the
other hand, a delay could be necessary for the probiotic to express
the genes required for the anti-Campylobacter activity, which
could explain why some studies do not show positive results.
In addition, infection by Campylobacter is rarely detected
in chicks that are less than a week old; flocks usually become
infected when the birds are 2–3 weeks of age (Neill et al.,
1984; Jacobs-Reitsma et al., 1995; Berndtson et al., 1996). In the
majority of the studies conducted to date, researchers inoculated
with C. jejuni in the very first days of life (Figure 5 and Table 3).
Different host factors can justify the variations in the results of
probiotic use in poultry (Otutumi et al., 2012). Chicken lineage
could potentially influence probiotic treatments. Recent studies
showed that behavior of C. jejuni in the broiler chicken may
differ considerably to that in chicken breeds used in experimental
studies (Humphrey et al., 2015). Modern rapidly growing
chicken breeds used in intensive production systems exhibited
a strong inflammatory response to C. jejuni infection that can
lead to diarrhea (Humphrey et al., 2014). As demonstrated
with Campylobacter, probiotics could have a different efficacy
depending on the chicken breeds. The immunologic status of the
animals is different between different chicken breeds (Korver,
2012) and therefore is also an inherent characteristic that could
modulate the probiotic action. Interactions of probiotics with
different chicken breeds need to be considered. Age of the
chicken when the probiotic is administrated could also affect
the activity of the probiotic strain. Indeed, Mohan et al. (1996)
have found that beneficial effects of probiotics on zootechnical
parameters were seen during the initial growth phase, suggesting
that during this stage of life the intestinal microbiota is still
in an unstable condition, and the microorganisms given orally
probably find a niche where they can occupy (Fuller, 1995).
Therefore, the existence of an intestinal microbiota at the
time of administration and the health of the host must be
FIGURE 5 | Comparison between (A) commercial broiler chicken production and (B) in vivo studies designed to evaluate the efficacy of probiotics to
reduce the colonization of C. jejuni. In almost all in vivo studies, the duration and/or artificial Campylobacter contamination are not in accordance with the duration
and natural Campylobacter contamination in commercial broiler chicken production.
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considered when a probiotic is supplemented for the suppression
of pathogenic bacteria (Siriken et al., 2003). Antimicrobial and
antiparasitic treatments received by the animals before or during
the probiotic administration could also influence the survival of
the probiotic strain (Jin et al., 1997).
With artificially colonized chicks, the origin of the pathogen
strain is very important as the ability to colonize chickens is
dependent on the original source of the isolate (Pielsticker et al.,
2012). In some studies, only human isolates of C. jejuni (81–
176, F38011) were used and might not be relevant for chicken
colonization trials. As we suggest for in vitro assays (Sections
Growth Inhibition Assays and Adhesion and Invasion Inhibition
Assays), it could be interesting to include in the trials reference
strains to compare results between different studies and field
strains to be closer to the field.
When natural contamination occurred, it raised a particularly
important point about Campylobacter: they exhibit high genetic
and phenotypic variability (Gripp et al., 2011). As a consequence,
they are not equally able to colonize chickens (Chaloner
et al., 2014) and probably not equally sensitive to probiotic
actions (Wine et al., 2009). Therefore, it could be important
to characterize these C. jejuni strains. In addition, research
on Campylobacter control has focused on C. jejuni and the
probiotic strains used in the in vivo trials showed an in vitro anti-
Campylobacter activity against C. jejuni. However, broilers can
also be contaminated by C. coli (Rivoal et al., 2005; Hue et al.,
2011) and when natural contamination occurred, C. jejuni could
not be distinguished from C. coli as the enumeration was done
by microbiological methods. It cannot be excluded that C. coli
was responsible for the contamination and therefore the in vivo
anti-Campylobacter activity was low or absent.
Samples used to enumerate Campylobacter may have an
impact on the results and their interpretation. Feces and
cloacal swabs are very useful for performing longitudinal studies
with repeated measures on one animal. Nevertheless, cloacal
swabs can only be used for detection and give information
on the prevalence of Campylobacter while Campylobacter
concentrations are also important when comparing an effect of
a treatment. Feces could induce a bias in the results because
bacterial diversity and community composition in fecal samples
differ from cecal content (Pauwels et al., 2015). Bahrndorff et al.
(2015) recently evaluated the colonization of individual broiler
chickens byC. jejuni over time. They pointed out large differences
between broiler chickens in the number of C. jejuni in cecal and
fecal samples at 4, 7, and 12 days post-infection (Bahrndorff
et al., 2015). These differences could be due to the fact that
this foodborne pathogen requires a microaerophilic atmosphere
(Macé et al., 2015) and this condition is not optimal in the fecal
samples. Cecal drops could be a valuable alternative to feces and
cloacal swabs in longitudinal studies (Pauwels et al., 2015).
The form and route of probiotic administration are two
critical points for a future industrial application. Fresh cultures
that are individually inoculated are clearly not possible at the
farm level, even if the probiotics are highly active and efficient.
It will be important for probiotic producers to use production
processes and modified preservation and administration
strategies to guarantee the delivery of active strains to the
poultry. As several papers have shown, the industrial processing
of a probiotic preparation has a fundamental impact on its
functionality in the host (Bron et al., 2012; Van Bokhorst-Van de
Veen et al., 2012). Viability, the presence or absence of pili, the
cell wall condition, the matrix or the growth stage of the probiotic
seem to have an important influence on its performance and its
interaction with the host (Papadimitriou et al., 2015). Defining
the mechanism of action of a probiotic might therefore also
include some critical parameters of the production process.
Their activity and survival during storage must also be assessed
(FAO/WHO, 2001). Little information on these aspects are
available for probiotics with an anti-Campylobacter. However,
several studies focusing on probiotics for poultry mentioned
that moisture and cell conditions have an impact on survival of
probiotics during long-term storage. Freeze-drying and freezing
with cryoprotective agents seemed to be suitable conditions
to store probiotic strains (Pascual et al., 1999). In addition,
Khoramnia et al. (2011) have shown that cryoprotectants
significantly increase storage life of freeze-died lactobacilli
probiotics, intended for poultry, during several months at
refrigerated temperature. The probiotic could be administrated
to poultry by different routes, including to animal feed. However,
inclusion to the commercial feed mixture can affect probiotic
survival by the temperatures used during the feed mixture
storage and in the chicken incubator rooms (Pascual et al., 1999).
Microencapsulation of probiotics appeared to be a promising
alternative to improve their viability and survival against adverse
conditions during processing, storage and gastrointestinal
passage (Baffoni et al., 2012; Dianawati et al., 2015). To our
knowledge, few probiotics, in the form of commercial feed
additives, have exhibited a strong anti-Campylobacter activity
(>2 log reduction) (Ghareeb et al., 2012; Guyard-Nicodème
et al., 2016).
Even if the purpose of these studies is to reduceCampylobacter
loads in poultry, it is important to keep in mind that the
final destination of the broilers is the retail market. The
administration of large amounts of bacteria could not only reduce
Campylobacter but also impair the homeostasis of the avian gut
microbiota. Indeed, this ecosystem is crucial for the fermentation
of undigested carbohydrates (Józefiak et al., 2004). Therefore, it
is necessary to examine the probiotic impact on performance
parameters including average daily feed intake, body weight gain
and feed conversion ratio. These parameters have not always been
assessed because of the lack of a group treated with the probiotic
and unchallenged with C. jejuni in the experimental design. In
addition to zootechnical parameters, it might be interesting to
monitor immune and inflammatory responses during animal
experiments (Awad et al., 2014a,b; Humphrey et al., 2014).
Impact on Consumers
When considering the results of the different studies summarized
in Table 3, an issue that needs to be addressed is the biological
meaning of Campylobacter reduction in broilers. For example,
the questions could be whether a statistically significant 0.5 log
reduction in C. jejuni has important effects on the risk for
consumers and what is the minimal reduction in order to
conclude that a probiotic is efficient. Quantitative microbial
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risk assessment analyses of human campylobacteriosis associated
with thermotolerant Campylobacter spp. in broiler chickens have
been performed. In Denmark, a reduction in Campylobacter
counts on chicken carcasses by 2 log predicted a 30-fold reduction
in the incidence of campylobacteriosis in humans (Rosenquist
et al., 2003). Another study conducted in Belgium demonstrated
that the incidence would be reduced by 48, 85, and 96% when
a 1 log, 2 log or 3 log reduction, respectively, of Campylobacter
contamination on carcasses was achieved (Messens et al., 2007).
Based on a quantitative microbiological risk assessment on
Campylobacter in broilers at EU level, Romero-Barrios et al.
(2013) estimated that the potential risk reduction would range
from 48 to 100% for reductions of 1–6 log in Campylobacter
in the intestines. According to these assessments, the minimum
reduction in cecal Campylobacter loads that needs to be achieved
to ensure a substantial reduction in human campylobacteriosis is
at least 1 log10 CFU/g (Nauta et al., 2016).
An added value might be to extend the work to assess the
impact of the probiotic strains on the prevalence or the level
of Campylobacter on processed birds, i.e., carcasses. This could
provide an overview of a part of the poultry chain production
from the farm to the slaughterhouse.
CONCLUSION
To conclude, research has shown that probiotics have potential
for limiting Campylobacter colonization in broiler chickens.
The oral administration of probiotic bacteria is advantageous,
as they are easy to administer, i.e., in feed or drinking
water, inexpensive to produce, and may persist in the animal.
In vitro studies can indicate a possible anti-Campylobacter
activity and yield useful information about the inhibition
mechanism involved. Nevertheless, given the limitations of
individual methods, no in vitro assay alone seems ideal to
affirm a potential anti-Campylobacter activity. Therefore, studies
must combine in vitro and in vivo methods to take into
account the complexity introduced by the host, the feed,
and the microbiota. This recommended combined approach
may use multiple complementary tools (cell cultures, animal
experiments) and address different points (molecular and overall
interactions). In vivo studies using defined bacterial strains and
various mixtures have shown promising results in reducing the
colonization of Campylobacter spp. in chicken.
This review highlights, in particular, the intensive use of
Lactobacillus spp., i.e., acidophilus, casei, crispatus, gasseri,
helveticus, pentosus, plantarum, rhamnosus, and salivarius,
which exhibit relevant in vitro and in vivo anti-Campylobacter
activities. In the future, it may be important to investigate
different and varied bacterial species.
Finally, a valuable perspective would be to look at strain
combinations enhanced by prebiotics. This strategy could be
relevant for additives to poultry feed for the reduction of food-
borne campylobacteriosis in humans. There is still a long way
to go because processing could influence the in vivo anti-
Campylobacter activity.
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